Novel biological substance from a fungus and the process for producing the same
AssigneeScience Union et Cie
InventorsNicole Simon-Lavoine, Marcel Forgeot
Life of this patent
Estimating the term…
Abstract
This invention relates to a biological substance extracted from the Mycelium of a Fusarium. This substance has a peptidolic structure with specific amino-acids into. This invention also relates to a process for producing the afore-said biological substance by culturing the strain of Fusarium and extracting the mycelium. The biological substance has a therapeutical use.
Claims17
A mixture of peptidolic substances obtained from the mycelium of Fusarium equiseti, said mixture being separable into four components by high pressure liquid chromatography, said components being designated A, B, C & D, said mixture, on acidic hydrolysis yielding .alpha.-hydroxy iso valeric acid and N-methyl Valine;
- N-methyl isoleucine and N-methyl allo iso leucine, and on alkaline hydrolysis yielding the lactone of .alpha. hydroxy isovaleroyl N-methyl Valine, the lactone of .alpha.-hydroxy isovaleroyl N-methyl isoleucine and the lactone of .alpha.-hydroxy iso valeroyl N-methyl allo iso leucine.
A pharmaceutical composition according to claim 11 wherein the amount of active ingredient ranges from 0.05 to 1 mg per unit dosage.
Dependencies are inferred from the claim text.